Headlines

Chewy Launches IPO; Valuation Pitched At $7B

The share price is expected to be between $17 and $19.

Published

5 years ago

June 3, 2019

PETS+ Staff

DANIA BEACH, FL — Chewy Inc. has launched the roadshow for its initial public stock offering.

Owner PetSmart Inc. puts Chewy’s proposed valuation at about $7 billion, Bloomberg notes.

Chewy is offering 5.6 million shares of its Class A common stock. A subsidiary of PetSmart is offering 36 million shares of Chewy’s Class A common stock, plus up to an additional 6.24 million shares that the underwriters have the option to purchase.

The initial public offering price is expected to be between $17 and $19 per share. The shares have been approved for listing on the New York Stock Exchange under the symbol CHWY.

Chewy intends to use the net proceeds from this offering for working capital and other general corporate purposes, according to a press release. Chewy will not receive any of the proceeds from the sale of shares offered by the subsidiary of PetSmart.

The online pet product retailer was acquired by PetSmart in 2017 in a $3.3 billion deal.

Related Topics:Chewy.com Latest News Top

PETS+ Staff

Since launching in 2017, PETS+ has won more than 20 major international journalism awards for its publication and website. Contact PETS+ editors at editor@petsplusmag.com.

click to Comment(Comment)

Reduce Your Pet’s Hip & Joint Discomfort with the Most Researched Hyaluronan on the Market

Nearly 60% of dogs and 90% of cats suffer from joint discomfort. Trixsyn joint supplement contains a patented and proven hyaluronic acid molecule for maximum efficacy to promote joint, bone, soft tissue, and cartilage health, keeping your pet feeling comfortable, for longer. Trixsyn is veterinarian recommended, safe and all-natural, and contains research-proven ingredients. Get your paws on the most-researched hyaluronic acid on the market. Learn more at Trixsyn.com.